Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "obesity and diabetes treatment"
Home
Kyungpook National University Hospital Team Wins Back-to-Back Awards at International Congress
A research team led by Professor Yoon Jong-pil of the Department of Orthopedic Surgery at Kyungpook National University Hospital won the Academic...
10/20/2026, 09:28 ET
Sam Chun Dang Pharm Secures Exclusive U.S. Licensing Deal for Oral Obesity and Diabetes Treatment
Sam Chun Dang Pharm has entered into a significant license-out agreement with an undisclosed U.S. partner for the commercialization of oral...
04/01/2026, 04:58 ET
"It Wasn't Just Weight Loss That Improved My Knees"...Ozempic Study Confirms Cartilage 'Metabolic Changes'
"Please lose some weight. " This is a common phrase heard when visiting a hospital for knee pain.
03/17/2026, 01:44 ET
Does Mounjaro Harm Eye Health? Long-Term Study Shows Diabetic Retinopathy Risk Actually Drops
Concerns that Eli Lilly’s popular weight-loss and diabetes treatment, Mounjaro, might exacerbate eye complications in...
02/13/2026, 02:04 ET
The Surprising Life-Saving Potential of Weight Loss Meds in Diabetic Foot Care
GLP-1 receptor agonists (such as Wegovy and Ozempic), currently dominating the headlines as weight loss medications,...
02/06/2026, 02:40 ET
Fatigue, Muscle Loss, and Belly Fat: Is Male Menopause Behind Your Middle-Age Changes?
By middle age, many men notice that they tire more easily, gain abdominal fat, or lose muscle mass.
10/20/2026, 09:28 ET
Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul
What will it take to build on the success of Lexraza, South Korea’s landmark lung cancer drug, and propel it into the...
10/16/2026, 22:38 ET
Hanmi’s ‘Epe’ Wins MFDS Approval, Becoming South Korea’s First Homegrown GLP-1 Obesity Drug
A domestically developed therapy has entered South Korea’s obesity treatment market, long dominated by imported...
10/16/2026, 22:37 ET
From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro
Efpeglenatide, a drug candidate whose development rights were once returned by a global pharmaceutical giant, is...
10/16/2026, 04:57 ET
Mild Cognitive Impairment Doesn’t Always Lead to Dementia—Early Diagnosis and Lifestyle Management Are Key
Sept. 21 marks Dementia Overcoming Day, a designated observance created to raise public awareness about preventing and...
09/29/2026, 09:41 ET
1
2
3
Next